Peptide laws in the United Kingdom

How the UK regulates peptides

Medicines in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012. A medicine needs a marketing authorisation, a UK licence, before it can be sold, and prescription-only medicines must be prescribed. Whether a peptide product counts as a medicine depends partly on how it is presented: an MHRA official said in April 2026 that peptide products may be sold as cosmetics, supplements and medicines and fall under different regulatory frameworks depending on their intended purpose ¹.

Which peptides are licensed

Our regulatory tracker checks each peptide against the electronic medicines compendium (EMC), which lists most, though not all, UK-licensed medicines. The table below is generated from that tracker.

The other 33 peptides in our regulatory tracker had no authorised product in the same source when read (latest read 2026-10-03): BPC-157, KPV, TB-500, MOTS-c, Emideltide (DSIP), Semax, Epitalon, GHK-Cu (injectable), Melanotan II, Cathelicidin (LL-37), Dihexa, PEG-MGF, Exenatide, Tesamorelin, Bremelanotide (PT-141), SS-31 (elamipretide), Retatrutide, CagriSema, Survodutide, Selank, Noopept, Cerebrolysin, Thymosin α-1, Thymopentin, GHRP-2 (pralmorelin), CJC-1295, Ipamorelin, Sermorelin, GHRP-6, Hexarelin, MK-677 (ibutamoren), AOD-9604, Tesofensine. Our Legal Status Checker shows each one with its source link.

The April 2026 MHRA investigation

In April 2026, following a Guardian investigation, the MHRA began investigating whether UK clinics were breaking the law by making claims about the benefits of experimental peptide therapies. An MHRA spokesperson said that if clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation under the Human Medicines Regulations 2012, and that the agency will take action against clinics identified as breaching the legal requirements ¹. Reports named BPC-157, MOTS-c, Cortexin and thymosin alpha-1 among the peptides the clinics offered ¹.

The MHRA also said there was little scientific evidence to support such health and wellness claims ¹. That matches what our encyclopedia finds for most of these compounds.

Research peptides and 'research use only'

Many UK sellers label peptides 'for research use only'. The MHRA's April 2026 statement turns on presentation: a product marketed with medicinal claims is treated as a medicine whatever its label, and selling an unlicensed medicine for human use falls under the medicines regulations ¹. Commentary from UK sellers and law firms differs on how far the 'research' framing protects a seller; we do not resolve that here, and we do not treat a research label as a statement about safety. Our guide to 'research use only' explains why.

Bringing medicines into the UK

GOV.UK's guidance on taking medicine in or out of the UK deals mainly with controlled drugs: you can bring up to 3 months' supply of a medicine containing a controlled drug, it must be carried in hand luggage, non-residents need a letter showing it was prescribed for them, and supplies above 3 months or posted to you will be taken away ². For medicines that do not contain a controlled drug, the Home Office guidance tells travellers to check the MHRA's import rules ³. Most peptides are not controlled drugs, but prescription-only status still applies to licensed ones. Our travel guide covers airport security and storage.

Getting a peptide legally

For a licensed peptide such as semaglutide, the route is a prescription and supply through a registered pharmacy. Medicines not licensed in the UK can still be prescribed by a UK clinician in some circumstances as unlicensed 'specials', according to Home Office guidance on travellers' medicines ³; that is a clinical decision, not a way to buy research peptides. Our Approved-Alternative Finder lists licensed options for common goals, and side effects can be reported through the MHRA's Yellow Card scheme.

Sport

UK athletes are bound by the WADA Prohibited List, applied by UK Anti-Doping. BPC-157 is prohibited under S0, and growth hormone secretagogues and releasing peptides are named under S2.2.4 ⁴. Our WADA hub lists each peptide.

Questions to check

• Is there a UK-licensed product, with a Summary of Product Characteristics on EMC?
• Is it prescribed and supplied by a registered pharmacy?
• Is a clinic making medicinal claims for an unlicensed peptide?
• Am I subject to anti-doping testing?

The bottom line

In the UK, licensed peptides such as semaglutide and tirzepatide are prescription medicines, and most research peptides, BPC-157 included, have no licence. The MHRA's position is that a peptide sold with medicinal claims is a medicine under the 2012 Regulations, and it investigated peptide clinics on that basis in 2026. A research label is not a licence.

Frequently asked questions

Are peptides legal in the UK?

Licensed peptide medicines are legal on prescription. Most research peptides have no UK licence, and the MHRA says peptides sold with medicinal claims are medicines regulated under the Human Medicines Regulations 2012.

Is BPC-157 legal in the UK?

It has no UK licence; we found no product on the electronic medicines compendium. The MHRA's 2026 investigation of peptide clinics named it among the peptides offered.

Can UK clinics sell peptide injections?

The MHRA said in April 2026 that clinics making medicinal claims for peptide injections are dealing in medicines subject to regulation, and it would act against breaches.

Can I bring peptides into the UK?

GOV.UK limits medicines containing controlled drugs to 3 months' supply carried with you; for other medicines it points to MHRA import rules. Prescription-only status still applies.

Related on Grey Peptides

• Legal Status Checker
• Are peptides legal?
• Peptide laws in Australia

Sources

1. MHRA statements on peptide clinics, April 2026, as reported by The Guardian (April 4, 2026) and Pharmacy Business (April 7, 2026). Read October 3, 2026.
2. GOV.UK. Take medicine in or out of the UK. Read October 3, 2026.
3. Home Office. Controlled drugs: personal licences (guidance for travellers, including non-controlled medicines and unlicensed 'specials'). GOV.UK; read October 3, 2026.
4. Grey Peptides regulatory tracker (UK: electronic medicines compendium, read October 3, 2026) and WADA hub (2026 Prohibited List). Read October 3, 2026.

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.